Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthijs C Brouwer

Showing results (251-260 of 269) with videos related to

Pageof 27
Sort By:
Trials|October 2, 2014
Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis planWilleke F Westendorp, Jan-Dirk Vermeij, Diederik W J Dippel, et al.
Lancet (London, England)|August 20, 2013
A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in EuropeJoppe W R Hovius, Bob de Wever, Maaike Sohne, et al.
The Journal of Infectious Diseases|December 17, 2013
Streptococcus pneumoniae arginine synthesis genes promote growth and virulence in pneumococcal meningitisJurgen R Piet, Madelijn Geldhoff, Barbera D C van Schaik, et al.
Elife|July 26, 2022
Pneumococcal genetic variability in age-dependent bacterial carriagePhilip H C Kremer, Bart Ferwerda, Hester J Bootsma, et al.
Communications Biology|July 8, 2026
LacR and TrxB are key virulence factors involved in pneumococcal meningitis as identified by a genome-wide association studyRutger Koning, Kin Ki Jim, Philip H C Kremer, et al.
Ebiomedicine|October 29, 2025
Anti-cytokine autoantibodies linked to susceptibility, bacterial load, and outcome in pneumococcal meningitis: prospective cohort studies in CNS infections, Alzheimer's disease, and Parkinson's diseaseRutger Koning, Nora Chekrouni, Lindsey B Rosen, et al.
Neurology|June 1, 2014
Genetic risk load according to the site of intracranial aneurysmsFemke N G van 't Hof, Mitja I Kurki, Rachel Kleinloog, et al.
Ebiomedicine|May 17, 2021
Clinical features and prognostic factors in Covid-19: A prospective cohort studySanne de Bruin, Lieuwe D Bos, Marian A van Roon, et al.
The Lancet. Respiratory Medicine|September 10, 2022
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialAlexander P J Vlaar, Martin Witzenrath, Pieter van Paassen, et al.
BMJ Open|November 25, 2016
Towards the genetic basis of cerebral venous thrombosis-the BEAST Consortium: a study protocolIoana Cotlarciuc, Thomas Marjot, Muhammad S Khan, et al.
Pageof 27

Showing results (251-260 of 269) with videos related to

Sort By:
Pageof 27
Trials|October 2, 2014
Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis planWilleke F Westendorp, Jan-Dirk Vermeij, Diederik W J Dippel, et al.
Lancet (London, England)|August 20, 2013
A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in EuropeJoppe W R Hovius, Bob de Wever, Maaike Sohne, et al.
The Journal of Infectious Diseases|December 17, 2013
Streptococcus pneumoniae arginine synthesis genes promote growth and virulence in pneumococcal meningitisJurgen R Piet, Madelijn Geldhoff, Barbera D C van Schaik, et al.
Elife|July 26, 2022
Pneumococcal genetic variability in age-dependent bacterial carriagePhilip H C Kremer, Bart Ferwerda, Hester J Bootsma, et al.
Communications Biology|July 8, 2026
LacR and TrxB are key virulence factors involved in pneumococcal meningitis as identified by a genome-wide association studyRutger Koning, Kin Ki Jim, Philip H C Kremer, et al.
Ebiomedicine|October 29, 2025
Anti-cytokine autoantibodies linked to susceptibility, bacterial load, and outcome in pneumococcal meningitis: prospective cohort studies in CNS infections, Alzheimer's disease, and Parkinson's diseaseRutger Koning, Nora Chekrouni, Lindsey B Rosen, et al.
Neurology|June 1, 2014
Genetic risk load according to the site of intracranial aneurysmsFemke N G van 't Hof, Mitja I Kurki, Rachel Kleinloog, et al.
Ebiomedicine|May 17, 2021
Clinical features and prognostic factors in Covid-19: A prospective cohort studySanne de Bruin, Lieuwe D Bos, Marian A van Roon, et al.
The Lancet. Respiratory Medicine|September 10, 2022
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialAlexander P J Vlaar, Martin Witzenrath, Pieter van Paassen, et al.
BMJ Open|November 25, 2016
Towards the genetic basis of cerebral venous thrombosis-the BEAST Consortium: a study protocolIoana Cotlarciuc, Thomas Marjot, Muhammad S Khan, et al.
Pageof 27